next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |review
My interest in this field evolved naturally because of my training in biochemistry, human genetics and epidemiology, as well as my research regarding the epidemiology of insulin-dependent diabetes mellitus (IDDM), which began in the early 1980�s. By the late 1980�s, studies from Massimo Trucco�s lab at our Diabetes Research Center led to the discovery of molecular markers of IDDM susceptibility (HLA-DQB1 alleles) associated with more than a 100-fold increase in risk. The magnitude of these disease associations were unparalleled. At the same time, our research center became a WHO Collaborating Center for Diabetes Registries, Research and Training (Ronald LaPorte and Janice Dorman, Co-Directors), coordinating the WHO Multinational Project for Childhood Diabetes, known as the DiaMond Project. The incidence registries established for DiaMond in countries around the world, the discovery of a strong molecular maker of IDDM susceptibility and my participation in these research efforts provided the perfect "natural setting" to embark on a career in molecular epidemiology.